Fuwai Hospital
Beijing, Beijing Municipality, 100037, China
Location status: Recruiting
Location contact
Aimin Dang, Doctor
PRINCIPAL_INVESTIGATOR
Naqiang Lv, Doctor
CONTACT
NCT Number: NCT02964364
Takayasu arteritis (TA) is a chronic large-vessel vasculitis that mainly affects the aorta and its major branches. The epidemiology and pathophysiology of TA is still unclear in China, although many studies have been done. Our previous study supporting by National Natural Science Foundation of China indicated the cytokines such as hs-CRP, NT-proBNP and tumor necrosis factor-alpha (TNF-α) can be used to monitor TA activity, and HLA gene alleles were associated with TA in Chinese han population. Further investigations with larger samples are needed to fully understand the a pathophysiology of TA. The purpose of this study is to build a Chinese national registry system for TA to obtain real-world information, such as current status of characteristics, diagnosis, disease activity, the severity of disease, treatment and outcomes of Chinese TA patients. To analysis and development of effective disease monitoring and treatment strategies.
Interested in participating?
Request Info5 year–80 year
All sexes
Observational
Beijing, Beijing Municipality, 100037, China
Location status: Recruiting
Aimin Dang, Doctor
PRINCIPAL_INVESTIGATOR
Naqiang Lv, Doctor
CONTACT
Takayasu arteritis (TA) is a chronic vasculitis that causes inflammation of the aorta and its main branches and is characterized by adventitial thickening and cellular infiltration of the tunica media, with local destruction of vascular smooth muscle cells and elastin. The disease is very rare but most commonly occurs in China. In the last decade, the results of our study indicated that HLA-DPB1, HLA-DQA1, HLA-DQB1 and HLA-DRB1 gene alleles were associated with TA in Chinese Han population. And the clinical features of patients with TA were analyzed. The cytokines such as hs-CRP, NT-proBNP and tumor necrosis factor-alpha (TNF-α) can be used to monitor TA activity. But there are still many unknown fields in TA, such as the epidemiology and pathophysiology. This study is to build a Chinese national registry system for TA to obtain real-world information, such as current status of characteristics, diagnosis, disease activity, the severity of disease, treatment and outcomes of Chinese TA patients. To analysis and development of effective treatment strategies.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years (2016-2026)
All-caused death at 10 years.
Time frame: 10 years (2016-2026)
the major cardiac and cerebrovascular events (MACCE) defined as the composite of all heart failure, all stroke, all myocardial infarction (MI), or any revascularization at 10 years.
Contact information is provided by the study sponsor or research team.
Aimin Dang, MD,PhD
CONTACT
Naqiang lv, MD,PhD
CONTACT
Aimin Dang
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07087912
Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
São Paulo, Brazil
View Trial DetailsNCT07077304
ANCA Associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Paris, France
View Trial DetailsNCT07491913
Aortic Arch Syndromes, Aortic Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02967068
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes
Boston, Massachusetts, United States
View Trial Details